An increasing number of studies have shown that PTBP1‐mediated mRNA alterations have essential functions in tumours, including colorectal cancer [30], hepatocellular carcinoma [31], breast cancer [32], and oesophageal squamous cell carcinoma [33]. This evidence concerns the gene PTBP1 and hepatocellular carcinoma.